Parte un progetto dell’Aou di Cagliari
Risultati per: Nanotubi di DNA per terapie contro i tumori del cervello
Questo è quello che abbiamo trovato per te
Tumori e malattie autoimmuni, diagnosi più veloci l'IA
Parte un progetto dell’Aou di Cagliari
Verso nuove terapie per rigenerare cuore dopo infarto miocardio
Università Trieste e Monzino studiano un nuovo farmaco con Rna
Verso nuove terapie per rigenerare cuore dopo infarto miocardio
Università Trieste e Monzino studiano un nuovo farmaco con Rna
“Tumori, scegli la prevenzione”, al via campagna Fondazione Aiom
Promuoverà abitudini salutari per evitare insorgenza tumori
Tumore al seno, parte progetto per monitorare le terapie con una goccia di sudore
Finanziato con oltre 3 mln dall’Ue, partecipa l’Irst di Meldola
Durante l'allattamento un ormone nel cervello rinforza le ossa
Apre nuove prospettive contro l’osteoporosi
The Role of DNA Methylation in Gastrointestinal Disease: An Expanded Review of Malignant and Non-Malignant Gastrointestinal Diseases
Esophageal, colorectal, pancreatic, hepatocellular, and gastric cancer together impact millions of patients worldwide each year, with high overall mortality rates and are increasing in incidence. Additionally, premalignant gastrointestinal diseases such as Barrett’s esophagus and inflammatory bowel disease are also increasing in incidence. However, involvement of aberrant DNA methylation in these diseases is incompletely understood, especially given recent research advancements in this field. Here, we review knowledge of this epigenetic mechanism in gastrointestinal preneoplasia and neoplasia, considering mechanisms of action, genetic and environmental factors, and CpG island methylator phenotype.
Identificato il meccanismo che impedisce l’efficacia delle terapie contro il melanoma
Errors in Figure 4 and Incorrect DNA Sequencing Manufacturer
In the Original Investigation titled “Neoadjuvant Nivolumab Plus Chemotherapy Followed by Response Adaptive-Therapy for HPV+ Oropharyngeal Cancer: OPTIMA II Phase 2 Open-Label Nonrandomized Clinical Trial,” published online on June 6, 2024, in JAMA Oncology, Figure 4 contained transposed labels on the curves in panel B, and the DNA Safe-Sequencing System was not accurately attributed to Sysmex Inostics Inc. This article was corrected online.
Circulating Tumor DNA-Guided De-Escalation Targeted Therapy for Advanced Lung Cancer
This nonrandomized controlled trial assesses the feasibility of using a circulating tumor DNA−guided adaptive de-escalation tyrosine kinase inhibitor strategy in patients with advanced non−small cell lung cancer to achieve complete remission after local consolidative therapy.
Stool and Blood DNA Tests for Colorectal Cancer Screening
New England Journal of Medicine, Volume 390, Issue 23, Page 2222-2225, June 20, 2024.
Milano, apre il Centro di Medicina aerospaziale per le terapie avanzate
Frutto dell’accordo quadro tra l’Università di Milano, l’Aeronautica Militare e la Fondazione Ca’ Granda Ospedale Maggiore Policlinico, il Cemata si propone come esempio di think-tank civile-militare